• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

GW Pharmaceuticals PLC

+ Add to Watchlist

GWPH:US

46.2000 USD 1.5600 3.49%

As of 20:10:00 ET on 04/17/2014.

Snapshot for GW Pharmaceuticals PLC (GWPH)

Open: 44.3300 Day's Range: 43.5000 - 47.5900 Volume: 298,295
Previous Close: 44.6400 52wk Range: 8.4600 - 86.4500 1-Yr Rtn: -

Stock Chart for GWPH

No chart data available.
  • GWPH:US 46.2000
  • 1D
  • 1M
  • 1Y
44.6400
Interactive GWPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GWPH

Current P/E Ratio (ttm) -
Estimated P/E(09/2014) -
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (09/2014) -0.4170
Est. PEG Ratio -
Market Cap (M USD) 820.37
Shares Outstanding (M) 17.76
30 Day Average Volume 417,740
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/20/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GWPH

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for GWPH

GW Pharmaceuticals plc researches and develops cannabinoid prescription medicines for the treatment of cancer pain, Multiple Sclerosis, and neuropathic pain.

Geoffrey William GuyChairman/FounderJustin David GoverChief Executive Officer
Adam David GeorgeCFO/SecretaryChristopher John Tovey "Chris"Chief Operating Officer
More Company Profile & Key Executives for GWPH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil